| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 2,152,300 | 1,976,200 | 1,955,400 | 2,195,300 | | Cost of Revenue | 1,545,000 | 1,427,500 | 1,265,700 | 1,803,900 | | | Gross Profit | 607,300 | 548,700 | 689,700 | 391,400 | | | Operating Expenses | | Research Development | 29,400 | 24,100 | 29,600 | 33,200 | | Selling General and Administrative | 542,400 | 232,300 | 233,500 | 244,100 | | Non Recurring | (292,500) | 314,700 |
-
|
-
| | Others |
-
| (174,200) | 174,200 |
-
| | | | Total Operating Expenses |
-
| 396,900 |
-
|
-
| | | | Operating Income or Loss | 328,000 | 151,800 | 252,400 | 114,100 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
| (8,000) | (16,500) | 24,500 | | Earnings Before Interest And Taxes | 248,000 | 172,300 | 287,400 | 138,600 | | Interest Expense | 27,900 | 27,500 | 30,000 | 36,500 | | Income Before Tax | 220,100 | 144,800 | 257,400 | 102,100 | | Income Tax Expense | 86,300 | 25,400 | 66,500 | 7,100 | | Minority Interest |
-
| (4,800) | (1,600) | (5,000) | | | | Net Income From Continuing Ops | 246,000 | 114,600 | 189,300 | 90,000 | | | Non-recurring Events | | Discontinued Operations | (2,100) | (1,400) | 16,300 | (21,400) | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 243,900 | 113,200 | 205,600 | 68,600 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $243,900 | $113,200 | $205,600 | $68,600 |
|
0.05% Nasdaq 
Income Statement
